For an 82-year-old client taking 12 different medications, the risk of adverse drug events (ADEs) is exponentially increased due to polypharmacy. While all the listed actions are valuable components of a comprehensive care plan, the nurse's most important priority is to first establish a complete and accurate picture of what the client is actually taking. This is achieved through a comprehensive medication reconciliation and review. This foundational step directly addresses the primary source of potential harm: unidentified drug interactions, inappropriate medications, and therapeutic duplications. Without this critical analysis, actions like education, pill organizers, or more frequent appointments are built on a potentially flawed and unsafe medication list.
The systematic review by Zavaleta-Monestel et al. confirms that polypharmacy is directly associated with medication-related harm, including adverse drug events and drug-drug interactions [1]. A comprehensive review is the proactive clinical activity that identifies these risks before they translate into patient harm. The review by Ucarer et al. further supports this by highlighting that a hospitalization or clinical encounter represents a critical opportunity to optimize medication therapy through Quality Use of Medicines (QUM) activities, which are rooted in a thorough review of the patient's current regimen [2].
The other options, while important, are secondary because they are interventions that should follow, not precede, a safety review:
The NCLEX-RN examination frequently tests the concept of prioritization using the nursing process. In this scenario, the nurse is in the assessment phase. A comprehensive medication reconciliation is the critical assessment action that gathers data about all substances the client is taking (prescriptions, over-the-counter drugs, supplements) and analyzes them for safety. This directly aligns with the findings of Zavaleta-Monestel et al., whose systematic review evaluated the effectiveness of pharmacist-led deprescribing interventions, a process that fundamentally begins with a thorough medication review to identify inappropriate prescribing and potential drug-drug interactions [1]. The review by Ucarer et al. reinforces that hospitalization or a clinical assessment is a key "opportunity to optimise medication therapy," and this optimization is impossible without first conducting the reconciliation and review to understand the baseline [2].
Matos and Pinheiro further clarify the nurse's crucial role, stating that as clinicians responsible for close patient monitoring, nurses contribute to the appropriate use of medications and the proper discontinuation of harmful ones [3]. This responsibility begins not with education or compliance aids, but with a critical safety assessment of the medication list itself. The challenges to implementing such a review, including patient resistance and systemic barriers, are well-documented by Yang et al., which underscores why the nurse’s deliberate, prioritized action to conduct this review is so vital . By identifying a potentially inappropriate medication or a major interaction, the nurse can prevent an adverse event such as a fall from hypotension, acute kidney injury, or a dangerous bleed—harms that are far more immediate and severe than non-adherence.
For an older adult on 12 medications, the first priority is a comprehensive medication reconciliation to detect drug interactions, therapeutic duplications, and potentially inappropriate medications before implementing other safety strategies.
A thorough review identifies risks like anticholinergic burden, CNS depression, or QT prolongation that are common with polypharmacy. Use validated tools such as the Beers Criteria or STOPP/START to guide deprescribing.
Do not rely solely on the patient's self-report or a single pharmacy record. Verify the actual regimen by checking multiple sources, including specialist prescriptions and over-the-counter or herbal supplements, to create a complete picture.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.